Deepika Singh

About

I am currently working as a Postdoctoral Fellow at Greehey Children Cancer Research Institute, UT Health San Antonio, Texas. My current research interest includes development of anti-cancer therapeutics for cancer immunotherapy. Besides this I also aim to study the mechanism that regulates progression of cancer stem cells in drug resistant tumor and development of nanoparticles based drug delivery to tumor.

Employment

• The University of Texas Health Science Center at San Antonio Greehey Children's Cancer Research Institute Postdoctoral Fellow
  2021 - Present
• Deshpande Laoratoties Pvt. Ltd. Project assistant
  2010 - 2011

Education

• Institute of Life Sciences PhD
  2016 - 2021
• Barkatullah Vishwavidyalaya M. Sc.
  2012 - 2014
• Barkatullah University B. Sc.
  2008 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (30)

• Data from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.c.8332044
  +Save
• Figure SI1 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.31442769
  +Save
• Figure SI2 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.31442766
  +Save
• Figure SI3 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.31442760
  +Save
• Figure SI4 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.31442754
  +Save
• Figure SI5 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.31442751
  +Save
• Figure SI6 from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.31442748
  +Save
• Table S1A from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.31442745
  +Save
• Table S1B from Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  2026 DOI: 10.1158/0008-5472.31442742
  +Save
• Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Antitumor Immunity
  Cancer Research 2026 DOI: 10.1158/0008-5472.CAN-25-0521
  +Save